Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297980 · ClinicalTrials.gov registry record · NA
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
A NA study of Type 1 Diabetes and Hypoglycemia, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06297980: Recruiting NA study of Type 1 Diabetes and Hypoglycemia, sponsored by University of Colorado, Denver.
NCT06297980 is a NA study of Type 1 Diabetes and Hypoglycemia that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 150 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06297980, a NA study of Type 1 Diabetes and Hypoglycemia, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary aim is to examine how the menstrual cycle and use of hormonal birth control impact patient-reported outcomes and glycemic responses to physical activity.
Primary Outcome
time spent with glucose 70-180mg/dL on continuous glucose monitor
Conditions Studied
Interventions
- OTHER Personalized modifications to treatment to address menstrual cycle effects on glycemia
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT06297980 shows while recruiting
NCT06297980 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (80% lower).
The record links to 4 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Personalized modifications to treatment to address menstrual cycle effects on glycemia is the first listed.
NCT06297980 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06297980 about?
NCT06297980 is a clinical study titled "Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes". The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary ...
What is the current status of trial NCT06297980?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-03-15. Estimated completion is 2026-10-31.
What conditions does trial NCT06297980 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Hypoglycemia, Menstruation Disturbances, Hyperglycaemia Due to Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT06297980?
The interventions under investigation include: Personalized modifications to treatment to address menstrual cycle effects on glycemia (OTHER).
Who is sponsoring clinical trial NCT06297980?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297980 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06297980's enrollment target sits among peer trials
150 37th of 198 higher than 160 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI